Cargando…
Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19
Many severe illnesses with a systemic impact may cause activation of coagulation. While systemic activation of coagulation leads to a coagulopathy that follows many common activation pathways and failure of endogenous regulatory anticoagulant systems, underlying conditions may utilize distinctive pa...
Autor principal: | Levi, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171377/ https://www.ncbi.nlm.nih.gov/pubmed/34095755 http://dx.doi.org/10.1097/HS9.0000000000000571 |
Ejemplares similares
-
COVID-19 coagulopathy: is it disseminated intravascular coagulation?
por: Levi, Marcel, et al.
Publicado: (2020) -
Thrombosis and coagulopathy in COVID‐19: An illustrated review
por: Levi, Marcel, et al.
Publicado: (2020) -
The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020) -
Proposal of the Definition for COVID-19-Associated Coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2021) -
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence
por: Ragnoli, Beatrice, et al.
Publicado: (2023)